To investigate whether the observed effects on viability, differentiation, and tumorigenesis could be potentiated by two NHRs, we transduced the BE(2)-GR overexpressing cells with ERα, and extended our study to two additional MYCN-amplified NB cell lines, IMR32 and KCN69n. The gene discussed is ESR1; the disease is neuroblastoma.